Last reviewed · How we verify

NCT06871631

Serum Vitamin D and Gingival Crevicular Fluid Levels of Osteocalcin and N-Terminal Telopeptide

Completed Last updated 12 March 2025
What this trial tests

trial in D Vitamin Deficiency in 120 participants. Completed in 15 February 2025.

Timeline
10 June 2018
Primary endpoint
17 April 2022
15 February 2025

Quick facts

Lead sponsorOndokuz Mayıs University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date10 June 2018
Primary completion17 April 2022
Estimated completion15 February 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Ondokuz Mayıs University

Who can join

Adults 25 to 40, male only, with D Vitamin Deficiency or Osteocalcin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines the relationship between serum vitamin D levels and bone metabolism markers-osteocalcin and N-terminal telopeptide (NTx)-in gingival crevicular fluid (GCF) of periodontally healthy and periodontitis patients. A total of 120 male participants (60 healthy, 60 with periodontitis) aged 25-40 were included and categorized based on their serum vitamin D levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ondokuz Mayıs University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06871631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing